Related Experiment Videos
NF-kappaB in cancer: a marked target
1Ben May Institute for Cancer Research, The University of Chicago, 5841 S. Maryland Avenue, MC 60627, Chicago, IL 60637, USA. alin@huggins.bsd.uchicago.edu
Seminars in Cancer Biology
|March 26, 2003
Summary
Cancer develops when cell proliferation outpaces programmed cell death (apoptosis). The transcription factor NF-kappaB promotes proliferation and inhibits apoptosis, driving malignant growth and cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- The balance between cell proliferation and programmed cell death (apoptosis) is crucial for preventing oncogenesis.
- Deregulation of apoptosis, alongside uncontrolled cell proliferation, significantly contributes to cancer development.
- Inhibiting apoptosis allows damaged tumor cells to survive, promoting cancer initiation and resistance to therapy.
Purpose of the Study:
- To elucidate the role of the transcription factor NF-kappaB in regulating the balance between proliferation and apoptosis in oncogenesis.
- To understand how NF-kappaB influences tumor cell survival and malignant growth.
Main Methods:
- Analysis of the regulatory functions of NF-kappaB in cellular proliferation.
- Investigation of NF-kappaB's impact on the apoptotic pathway.
- Correlation of NF-kappaB activity with oncogenic processes.
Main Results:
- NF-kappaB was identified as a key regulator in oncogenesis.
- NF-kappaB was shown to promote cell proliferation.
- NF-kappaB was demonstrated to inhibit apoptosis, thereby tipping the balance towards malignant growth.
Conclusions:
- The transcription factor NF-kappaB plays a critical role in cancer development by promoting proliferation and inhibiting apoptosis.
- Targeting NF-kappaB may offer a therapeutic strategy to restore apoptotic balance and combat cancer.